95 related articles for article (PubMed ID: 6180128)
1. The role of liver in the catabolism of human alpha- and beta-interferon.
Bocci V; Pacini A; Bandinelli L; Pessina GP; Muscettola M; Paulesu L
J Gen Virol; 1982 Jun; 60(Pt 2):397-400. PubMed ID: 6180128
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of interferon: hepatic clearance of native and desialylated interferon.
Bocci V; Pacini A; Pessina GP; Bargigli V; Russi M
J Gen Virol; 1977 Jun; 35(3):525-34. PubMed ID: 881617
[TBL] [Abstract][Full Text] [Related]
3. The role of sialic acid in determining the survival of circulating interferon.
Bocci V; Pacini A; Pessina GP; Bargigli V; Russi M
Experientia; 1977 Feb; 33(2):164-6. PubMed ID: 844537
[TBL] [Abstract][Full Text] [Related]
4. Renal metabolism of homologous serum interferon.
Bocci V; Di Francesco P; Pacini A; Pessina GP; Rossi GB; Sorrentino V
Antiviral Res; 1983 Mar; 3(1):53-8. PubMed ID: 6191655
[TBL] [Abstract][Full Text] [Related]
5. Differences in sialic acid content of human interferons.
Morser J; Kabayo JP; Hutchinson DW
J Gen Virol; 1978 Oct; 41(1):175-8. PubMed ID: 702115
[TBL] [Abstract][Full Text] [Related]
6. The role of sialic acid in the functional activity and the hepatic clearance of C1-INH.
Minta JO
J Immunol; 1981 Jan; 126(1):245-9. PubMed ID: 7451969
[TBL] [Abstract][Full Text] [Related]
7. [Study of the catabolism of interferon, using the isolated and perfused liver].
Pessina GP; Pacini A; Bargigli V; Russi-Sorce M; Bocci V
Boll Soc Ital Biol Sper; 1976 May; 52(10):651-7. PubMed ID: 949376
[No Abstract] [Full Text] [Related]
8. Interferon as a modifier of estrogen receptors.
Dimitrov NV; Meyer CJ; Strander H; Einhorn S; Cantell K
Ann Clin Lab Sci; 1984; 14(1):32-9. PubMed ID: 6198954
[TBL] [Abstract][Full Text] [Related]
9. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
Edy VG; Billiau A; De Somer P
J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
[TBL] [Abstract][Full Text] [Related]
10. Renal filtration, absorption and catabolism of human alpha interferon.
Bocci V; Pacini A; Muscettola M; Paulesu L; Pessina GP; Santiano M; Viano I
J Interferon Res; 1981; 1(3):347-52. PubMed ID: 6180066
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobicity of neuraminidase-treated rabbit interferon.
Jeng DK
Proc Soc Exp Biol Med; 1977 Apr; 154(4):534-7. PubMed ID: 859858
[No Abstract] [Full Text] [Related]
12. Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA).
Thomas P; Zamcheck N
Dig Dis Sci; 1983 Mar; 28(3):216-24. PubMed ID: 6337795
[TBL] [Abstract][Full Text] [Related]
13. Interferon assay anomaly variation of interferon response with cell type and sialic acid content.
Schwartz AA; Villani-Price D
Adv Exp Med Biol; 1978; 110():153-7. PubMed ID: 727039
[TBL] [Abstract][Full Text] [Related]
14. No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.
Mogensen KE; Pyhälä L; Törmä E; Cantell K
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Jun; 82(3):305-10. PubMed ID: 4368958
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.
Vilcek J; Sulea IT; Zerebeckyj IL; Yip YK
J Clin Microbiol; 1980 Jan; 11(1):102-5. PubMed ID: 7354125
[TBL] [Abstract][Full Text] [Related]
16. Distribution of interferon in body fluids and tissues.
Bocci V
Tex Rep Biol Med; 1977; 35():436-42. PubMed ID: 358467
[No Abstract] [Full Text] [Related]
17. Pulmonary catabolism of interferons: alveolar absorption of 125I-labeled human interferon alpha is accompanied by partial loss of biological activity.
Bocci V; Pessina GP; Pacini A; Paulesu L; Muscettola M; Mogensen KE
Antiviral Res; 1984 Aug; 4(4):211-20. PubMed ID: 6486767
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
[TBL] [Abstract][Full Text] [Related]
19. Catabolic sites of human interferon-gamma.
Bocci V; Pacini A; Pessina GP; Paulesu L; Muscettola M; Lunghetti G
J Gen Virol; 1985 Apr; 66 ( Pt 4)():887-91. PubMed ID: 3920351
[TBL] [Abstract][Full Text] [Related]
20. Multiple active sites on human interferons.
Paucker K; Dalton BJ; Ogburn CA; Törmä E
Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4587-91. PubMed ID: 53841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
